These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7535522

  • 1. CD44 isoforms during differentiation and development.
    Ruiz P, Schwärzler C, Günthert U.
    Bioessays; 1995 Jan; 17(1):17-24. PubMed ID: 7535522
    [Abstract] [Full Text] [Related]

  • 2. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF, Zhu D, Bourguignon LY.
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [Abstract] [Full Text] [Related]

  • 3. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL.
    Biochem Biophys Res Commun; 1994 Apr 29; 200(2):1015-22. PubMed ID: 7513991
    [Abstract] [Full Text] [Related]

  • 4. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ, Lee HS, Ho LI, Lee WH, Ding JH.
    Biochem Mol Biol Int; 1994 Jul 29; 33(4):743-9. PubMed ID: 7526922
    [Abstract] [Full Text] [Related]

  • 5. Expression of alternatively spliced CD44 mRNA in sheep renal allografts.
    Krishnan R, Kireta S, Carter JK, Grooby WL, Rao MM, Russ GR.
    Transplant Proc; 1995 Jun 29; 27(3):2170-1. PubMed ID: 7540778
    [No Abstract] [Full Text] [Related]

  • 6. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H.
    Gynecol Oncol; 1995 Jun 29; 57(3):383-7. PubMed ID: 7539775
    [Abstract] [Full Text] [Related]

  • 7. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets.
    Protin U, Schweighoffer T, Jochum W, Hilberg F.
    J Immunol; 1999 Nov 01; 163(9):4917-23. PubMed ID: 10528194
    [Abstract] [Full Text] [Related]

  • 8. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ, Koopmann R, Imhof BA, Günthert U.
    J Pathol; 1994 Oct 01; 174(2):89-100. PubMed ID: 7525912
    [Abstract] [Full Text] [Related]

  • 9. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
    Hirano H, Screaton GR, Bell MV, Jackson DG, Bell JI, Hodes RJ.
    Int Immunol; 1994 Jan 01; 6(1):49-59. PubMed ID: 7511928
    [Abstract] [Full Text] [Related]

  • 10. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma.
    Hong RL, Pu YS, Hsieh TS, Chu JS, Lee WJ.
    J Urol; 1995 Jun 01; 153(6):2025-8. PubMed ID: 7538603
    [Abstract] [Full Text] [Related]

  • 11. The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1.
    Brooks L, Niedobitek G, Agathanggelou A, Farrell PJ.
    Am J Pathol; 1995 May 01; 146(5):1102-12. PubMed ID: 7538265
    [Abstract] [Full Text] [Related]

  • 12. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
    Harn HJ, Ho LI, Yu CP, Wang MW, Lee HS, Lin JJ, Lee WH, Isola NR, Cooper DL.
    Biochem Mol Biol Int; 1994 Feb 01; 32(2):233-8. PubMed ID: 7517252
    [Abstract] [Full Text] [Related]

  • 13. Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia.
    Yu Q, Toole BP.
    Dev Dyn; 1997 Jan 01; 208(1):1-10. PubMed ID: 8989516
    [Abstract] [Full Text] [Related]

  • 14. CD44 isoforms in metastatic cancer.
    Ponta H, Sleeman J, Dall P, Moll J, Sherman L, Herrlich P.
    Invasion Metastasis; 1997 Jan 01; 14(1-6):82-6. PubMed ID: 7544777
    [Abstract] [Full Text] [Related]

  • 15. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM.
    Cancer Res; 1998 Aug 15; 58(16):3719-26. PubMed ID: 9721884
    [Abstract] [Full Text] [Related]

  • 16. Influence of TGF-beta on murine thymocyte development in fetal thymus organ culture.
    Plum J, De Smedt M, Leclercq G, Vandekerckhove B.
    J Immunol; 1995 Jun 01; 154(11):5789-98. PubMed ID: 7538530
    [Abstract] [Full Text] [Related]

  • 17. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ, Rustgi AK.
    Cancer Res; 1995 May 01; 55(9):1831-5. PubMed ID: 7537174
    [Abstract] [Full Text] [Related]

  • 18. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
    Ermak G, Gerasimov G, Troshina K, Jennings T, Robinson L, Ross JS, Figge J.
    Cancer Res; 1995 Oct 15; 55(20):4594-8. PubMed ID: 7553635
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of BMP receptors in early mouse development.
    Roelen BA, Goumans MJ, van Rooijen MA, Mummery CL.
    Int J Dev Biol; 1997 Aug 15; 41(4):541-9. PubMed ID: 9303341
    [Abstract] [Full Text] [Related]

  • 20. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I, Dehmel A, Naundorf H, Finke LH.
    Anticancer Res; 1997 Aug 15; 17(5A):3633-45. PubMed ID: 9413216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.